| Disitamab Vedotin Combined With BCG Therapy in HER2-expressing High-risk Non-muscle Invasive Bladder Cancer (NCT06187506) | Fudan University | 2023-12-18 |
| A Prospective Study of Liquid Biopsy for Pancreatic Cancer Early Detection (NCT06166147) | Fudan University | 2023-12-18 |
| Liquid Biopsy-based Early Detection of Ovarian Cancer: a Proof-of-concept Study ( PROFOUND-OC ) (NCT06249308) | Fudan University | 2023-12-18 |
| A Perioperative Sintilimab and Chemotherapy in Esophageal Squamous Cell Carcinoma (NCT06152978) | Fudan University | 2023-12-15 |
| A Single-center, Prospective, Two Cohort Study of Surufatinib Combined With AG or AG in the First-line Treatment of Locally Advanced or Metastatic Pancreatic Cancer (NCT05969171) | Fudan University | 2023-12-05 |
| Tislelizumab Plus GX Versus Tislelizumab Plus GP in the Treatment of R/M NPC (NCT06177301) | Fudan University | 2023-12-01 |
| Thoracic Consolidation Radiotherapy for ES-SCLC Treated With Chemo-immunotherapy (NCT06187740) | Fudan University | 2023-12-01 |
| Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma (NCT02633514) | Fudan University | 2023-12-01 |
| Assessment of Early Pancreatic Cancer Prognosis by Minimal Residual Disease Using Multi-omics Approach (NCT06151691) | Fudan University | 2023-12-01 |
| Heterogeneity of Tertiary Lymphoid Structures Predicts Distinct Malignancy and Immune Microenvironment in Prostate Cancer: a Retrospective Cohort Study (NCT06484127) | Fudan University | 2023-12-01 |
| Cisplatin to Patients With Pancreatic Cancer and Homologous Recombination Deficiency (NCT06095141) | Fudan University | 2023-12-01 |
| Modified TOMOX-HAIC in Combination With Sintilimab and Bevacizumab Biosimilar for First-line Treatment of Advanced Hepatocellular Carcinoma (NCT06285019) | Fudan University | 2023-12-01 |
| A Study of Surufatinib in the Treatment of Advanced Soft Tissue Sarcoma (NCT06110650) | Fudan University | 2023-11-28 |
| A Study of PD-1 Inhibitors Combined With Fruquintinib and Chemotherapy in First-line Treatment of HER2-negative Advanced G/GEJ Cancer (NCT06158919) | Fudan University | 2023-11-20 |
| Real World Patient-Reported Outcomes in Chinese Her2+ EBC Patients Receiving (Neo) Adjuvant Anti-Her2 Based Therapy (NCT06161922) | Fudan University | 2023-11-07 |
| Wedge Resection for Ground-glass Opacity-featured Lung Cancer (ECTOP-1020) (NCT06102161) | Fudan University | 2023-11-01 |
| Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic Cancer (NCT06017284) | Fudan University | 2023-11-01 |
| A Phase II Study of T-DXd Plus SRT in HER2-positive Breast Cancer Brain Metastases (NCT06088056) | Fudan University | 2023-11-01 |
| Surveillance for Multifocal GGNs (NCT06097910) | Fudan University | 2023-11-01 |
| Fruquintinib With mFOLFOX6/FOLFIRI as First-Line Therapy for Conversion Surgery in mCRC (NCT06010888) | Fudan University | 2023-10-31 |
| Comparison of the Sugarbaker and Keyhole Repair for Parastomal Hernia (NCT06077318) | Fudan University | 2023-10-20 |
| Cohort of Twin Pregnancy and the Offspring (NCT05727085) | Fudan University | 2023-10-15 |
| Acute Health Effects of Low Temperature Exposure (NCT06076629) | Fudan University | 2023-10-10 |
| A Prospective Multicentre Clinical Study of Dynamic Monitoring of Plasma ctDNA Methylation Markers to Predict Recurrence of Colorectal Cancer After Complete Resection of Peritoneal Metastases (NCT06903325) | Fudan University | 2023-10-01 |
| Clinical Study of Huaier Granules in Patients With Advanced Breast Cancer Without Visceral Metastasis (NCT05860907) | Fudan University | 2023-10-01 |
| LRAMPS Versus LDP in Selected Early-stage Left-sided Pancreatic Cancer (NCT05939063) | Fudan University | 2023-10-01 |
| Tongxinluo Capsule in the Treatment of Cerebral Small Vessel Disease-A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study（TOPS-CSVD） (NCT06061692) | Fudan University | 2023-10-01 |
| Suture Repair vs Mesh Repair in the Treatment of Incarcerated Groin Hernia in Elderly Populations (NCT05966285) | Fudan University | 2023-09-30 |
| Postoperative Chemotherapy With/Without Radiotherapy and Immunotherapy for Colorectal Liver Metastases With High Risk of Locally Recurrence (NCT06120127) | Fudan University | 2023-09-25 |
| Clinical Study of T3011 Intravesical Instillation for Treatment of NMIBC Patients (NCT06427291) | Fudan University | 2023-09-21 |
| Envafolimab Combined With Recombinant Human Endostatin and First-line Chemotherapy Treat of Advanced Mucosal Melanoma (NCT06041724) | Fudan University | 2023-09-18 |
| Everolimus With Investigator's Choice of Chemotherapy in Advanced Triple-Negative Breast Cancer (TNBC) With Luminal Androgen Receptor (LAR) Subtype (NCT05954442) | Fudan University | 2023-09-13 |
| Cryoablation Combined with Tislelizumab Plus Lenvatinib in Previously Treated Solid Tumors (CASTLE-11) (NCT06032845) | Fudan University | 2023-09-13 |
| Multicenter Clinical Translational Study of "ICU-NO CRBSI" Based on Improvement Science (NCT06085690) | Fudan University | 2023-09-04 |
| Positive ER Expression Assessed by 18F-FES PET/CT in the MBC with ER-negative Primary Tumor (NCT06344767) | Fudan University | 2023-09-01 |
| Multimodal Deep Learning Signature for Evaluation of Response to Bevacizumab in Patient With Colorectal Cancer Liver Metastasis (NCT05354674) | Fudan University | 2023-09-01 |
| The Application of Probe Confocal Laser Endomicroscopy in Pancreatic Tumor Surgery (NCT06289803) | Fudan University | 2023-09-01 |
| Vitamin C to Quality of Life in Patients With Terminal Stage Pancreatic Cancer (NCT06018896) | Fudan University | 2023-08-25 |
| Neoadjuvant Chemoimmunotherapy Followed By Radiation Or Organ Preservation Surgery In Laryngeal/Hypopharyngeal Cancer (NCT06039631) | Fudan University | 2023-08-22 |
| Vitamin C to Chemotherapy Related Anemia in Pancreatic Cancer (NCT06018883) | Fudan University | 2023-08-20 |
| A Study of Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (BCTOP-T-N01) (NCT05999149) | Fudan University | 2023-08-20 |
| SRS for NSCLC With Oligo-residual Intracranial Disease After First-line 3rd Generation EGFR-TKI (NCT06020066) | Fudan University | 2023-08-10 |
| Surufatinib as Neoadjuvant Treatment for Locally Advanced or Metastatic Differentiated Thyroid Cancer (NCT05989425) | Fudan University | 2023-08-04 |
| Circulating Tumor DNA Monitoring in Platinum-resistant Ovarian Cancer (NCT05976932) | Fudan University | 2023-08-01 |
| Circulating Tumor DNA Methylation Guided Postoperative Adjuvant Chemotherapy for High-risk Stage II/III Colorectal Cancer (NCT05954078) | Fudan University | 2023-08-01 |
| Efficacy of Everolimus Combined With First-line Endocrine Therapy for HR+/HER2- SNF1-subtype Advanced Breast Cancer (NCT05949541) | Fudan University | 2023-07-26 |
| A Phase II Study of Advanced Salivary Gland Carcinoma Based on Molecular Typing (NCT05924256) | Fudan University | 2023-07-26 |
| DV Combined With Toripalimab for Renal Preservation in Solitary Kidney or Renal Insufficiency or Bilateral Multiple UTUC (NCT06354231) | Fudan University | 2023-07-20 |
| A Study to Explore the Third-line Treatment of Fruquintinib Combined With Serplulimab in Advanced Non-liver-limited Metastatic Colorectal Cancer: a Single-center, Phase 2 Study (NCT05954429) | Fudan University | 2023-07-20 |
| CD70-targeted CAR-NKT Cells(CGC729) Therapy in the Renal Cell Carcinoma (NCT06182735) | Fudan University | 2023-07-17 |
| 18F-fluoroestradiol (18F-FES) PET/CT Guided First-line Treatment for HR+/HER2- Metastatic Breast Cancer Patients (NCT06655545) | Fudan University | 2023-07-15 |
| Cetuximab+mFOLFOX6 VS. mFOLFOX6 Alone in RAS/BRAF Wild Type Patients With High-Risk Resectable CRLM (NCT05948072) | Fudan University | 2023-07-15 |
| Liposomal Irinotecan Based FOLFIRI With Bevacizumab in First-line Treatment of Advanced Colorectal Cancer (NCT05969899) | Fudan University | 2023-07-10 |
| The Clinical Value of an Artificial Intelligence System Using Abbreviated Protocol of Breast MRI Facilitates Classification of Breast Lessions (NCT05892380) | Fudan University | 2023-07-01 |
| A Study of HRXG-K-1939 and Adebrelimab in Patients With Advanced Solid Tumors (NCT05942378) | Fudan University | 2023-07-01 |
| Anatomical Resection VS. Nonanatomical Resection for Colorectal Liver Metastases With Gene Mutation or Right-sidedness (NCT05881746) | Fudan University | 2023-07-01 |
| Regorafenib Combined With TAS-102 Versus Regorafenib Monotherapy in Third or Later Line Therapy of mCRC (NCT05970705) | Fudan University | 2023-07-01 |
| Envafolimab Plus Docetaxel In Combination With or Without Trilaciclib Versus Docetaxel in Advanced NSCLC (NCT05910034) | Fudan University | 2023-07-01 |
| An Umbrella Trial Based on Molecular Pathway for Patients With Metastatic TNBC in First-line Treatment (FUTURE-Trop2) (NCT05928780) | Fudan University | 2023-07-01 |
| Postoperative Effects of Different Enterostomy Approaches (NCT05853094) | Fudan University | 2023-06-23 |
| Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03) (NCT05909332) | Fudan University | 2023-06-20 |
| Cryoablation Combined With Tislelizumab Plus Lenvatinib in 1L Treatment of Advanced HCC (CASTLE-10) (NCT05897268) | Fudan University | 2023-06-20 |
| The Efficacy and Safety of Fruquintinib Plus Chemotherapy as Second-line Treatment in Metastatic Colorectal Cancer (NCT05555901) | Fudan University | 2023-06-18 |
| Axillary Surgery De-escalation After Neoadjuvant Therapy Using Dedicate Breast PET (NCT05914402) | Fudan University | 2023-06-18 |
| Cryoablation Combined With Tislelizumab Plus Lenvatinib In Previously Treated Gastric Cancer Liver Metastasis (CASTLE-09) (NCT05893056) | Fudan University | 2023-06-16 |
| Circulating Tumor DNA Methylation Guided Postoperative Follow-up Strategy for Non-metastatic Colorectal Cancer (NCT05904665) | Fudan University | 2023-06-15 |
| EC-THP Versus TCbHP in HER2-positive Lymph Node Positive Early Breast Cancer (NCT05883852) | Fudan University | 2023-06-07 |
| A Randomized, Controlled, Open-label Clinical Trial of Adjuvant Intensive Therapy for HR+/ HER2-SNF4 Early Breast Cancer (NCT05889871) | Fudan University | 2023-06-01 |
| Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01) (NCT05891093) | Fudan University | 2023-06-01 |
| Adjuvant Pyrotinib and Capecitabine For HER2 Positive Micro Invasive Breast Cancer (NCT05861271) | Fudan University | 2023-06-01 |
| TCb vs EC-T in High Risk ER+/HER2- Breast Cancer (NCT05901428) | Fudan University | 2023-06-01 |
| A Multi-center, Randomized, Open-label, Phase III Study Comparing PD-1 Inhibitor Combined With Antivascular Therapy and Anthracycline/Taxane-based Adjuvant Chemotherapy Versus Anthracycline/Taxane-based Adjuvant Chemotherapy Alone in Patients With Operable Triple-negative Breast Cancer (NCT05862064) | Fudan University | 2023-06-01 |
| Multimodal Model for Efficacy Prediction Cetuximab in Colorectal Cancer Liver Metastasis Patient (NCT05873972) | Fudan University | 2023-06-01 |
| A Home Telemonitoring System for Wearable Fetal-ECG and EHG Acquisition During Pregnancy (NCT06031142) | Fudan University | 2023-05-29 |
| Abemaciclib, Palbociclib or Dalpiciclib Combined with Endocrine Therapy As First-line Treatment in HR Positive, HER2 Negative Unresectable or Metastatic Breast Cancer (NCT06344780) | Fudan University | 2023-05-20 |
| Initial CDK 4/6 Inhibitor Plus Endocrine Therapy Versus Initial Chemotherapy in HR Positive, HER2 Negative Unresectable or Metastatic Breast Cancer (NCT06344793) | Fudan University | 2023-05-20 |
| Oncolytic Virotherapy Combined With Tislelizumab Plus Lenvatinib in Patients With Advanced Biliary Tract Cancer (OPTIONS-05) (NCT05823987) | Fudan University | 2023-05-16 |
| HAIC Combined With Cadonilimab and Regorafenib as 2nd-line Treatment for ICC (NCT06335927) | Fudan University | 2023-05-11 |
| Disitamab Vedotin, Fruquintinib and Tislelizumab in Second-line Treatment for HER2-positive MGC (NCT05982834) | Fudan University | 2023-05-09 |
| Adjuvant Study of Pyrotinib in Combination With Trastuzumab in HER2 Positive Invasive Breast Cancer (NCT05841381) | Fudan University | 2023-05-06 |
| Transcutaneous Electrical Nerve Stimulation in Nerve-Sparing Radical Hysterectomy: Effects on Bladder Management and Quality of Life in Cervical Cancer (NCT07070687) | Fudan University | 2023-05-02 |
| Long-term Prognosis for Non-functional Neuroendocrine Tumors of the Pancreatic Body and Tail ≤ 3cm (NCT05907824) | Fudan University | 2023-05-01 |
| Combination of Chidamide and Fulvestrant for HR+/HER2- Breast Cancer That Has Failed Previous CDK4/6 i Adjuvant Therapy (NCT05806047) | Fudan University | 2023-05-01 |
| Maximal Cytoreductive Therapies on Post-treatment Metastases in Pts With mHSPC During Apalutamide Plus ADT Treatment (NCT05717582) | Fudan University | 2023-05-01 |
| The Efficacy and Safety of The Fuzuloparib Combination With Bevacizumab (NCT05819060) | Fudan University | 2023-04-30 |
| Cryoablation Combined With Sintilimab Plus Lenvatinib in 1L Treatment of Advanced ICC (CASTLE-ICC-Chemo-free) (NCT05835245) | Fudan University | 2023-04-28 |
| A Cohort Study of Musculoskeletal Health in Patients With Breast Cancer During Aromatase Inhibitors Therapy (NCT05921617) | Fudan University | 2023-04-27 |
| Regorafenib Alone or in Combination With Hypofractionated/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal Cancer (NCT05963490) | Fudan University | 2023-04-25 |
| Precise Treatment for BLIS Subtype of TNBC in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer (NCT05806060) | Fudan University | 2023-04-25 |
| Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018) (NCT06031246) | Fudan University | 2023-04-01 |
| Effect of Hepatectomy on the Prognosis of Patients With Nasopharyngeal Carcinoma Liver Metastases (NCT05771025) | Fudan University | 2023-04-01 |
| Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019) (NCT06031181) | Fudan University | 2023-03-31 |
| FUSCC Refractory TNBC Platform Study (FUTURE2.0) (NCT05749588) | Fudan University | 2023-03-30 |
| Cryoablation Combined With Sintilimab Plus Lenvatinib in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Biliary Tract Cancer （CASTLE-08） (NCT05781074) | Fudan University | 2023-03-23 |
| Camrelizumab in Combination With Cetuximab and Chemotherapy for Relapsed/Metastatic HNSCC Patients (NCT05673577) | Fudan University | 2023-03-22 |
| Famitinib in Combination With Camrelizumab and TPC in The First-line Treatment of Immunomodulatory Locally Advanced or Metastatic TNBC. (NCT05760378) | Fudan University | 2023-03-17 |
| Evaluate the Efficacy and Safety of Serplulimab Plus Chemotherapy in Neoadjuvant and Adjuvant Treatment of Resectable NSCLC (ECTOP-1013) (NCT05775796) | Fudan University | 2023-03-15 |
| The Efficacy of Compression/Ice Gloves/Socks in Patients With UTD1-induced Neuropathy. (NCT07638774) | Fudan University | 2023-03-15 |
| Different Targeted Antibody-drug Conjugates For HER2 Ultra-low or No Expression Advanced Breast Cancer（GALAXY） (NCT05824325) | Fudan University | 2023-03-14 |
| Transcriptomic Analysis of Incisional Hernia Based on High-throughput Sequencing Technology (NCT06366581) | Fudan University | 2023-03-01 |